Recommended Starting Dose of Methadone for OUD
The initial methadone dose should be 20-30 mg administered under supervision when withdrawal symptoms are present but no signs of sedation or intoxication exist, with a maximum first-day total dose not exceeding 40 mg. 1
Initial Dosing Protocol
The FDA-approved dosing strategy is clear and should be followed strictly 1:
- First dose: 20-30 mg (never exceed 30 mg as a single initial dose)
- Same-day adjustment: After 2-4 hours (when peak levels occur), if withdrawal persists, an additional 5-10 mg may be given
- Day 1 maximum: Total daily dose should not ordinarily exceed 40 mg
This conservative approach exists because deaths have occurred in early treatment due to cumulative effects during the first several days of dosing 1. Methadone's elimination half-life (8-59 hours) is substantially longer than its analgesic duration (4-8 hours), and steady-state concentrations are not reached until 3-5 days of dosing 1.
First Week Titration
During the initial week, dose adjustments should be made cautiously based on withdrawal control at expected peak activity (2-4 hours post-dose). Patients must understand that the dose will "hold" for longer periods as tissue stores accumulate 1.
Target Maintenance Dosing
While the question asks about starting doses, context matters: the therapeutic goal is 80-120 mg/day for maintenance treatment 1. This range prevents withdrawal for 24 hours, reduces cravings, and blocks euphoric effects of illicit opioids. Evidence shows that higher doses (80-100 mg) result in significantly lower rates of opioid-positive urine samples (53.0% vs 61.9%, P=0.047) compared to moderate doses (40-50 mg) 2.
Contemporary Context: The Fentanyl Era
Recent evidence suggests accelerated titration protocols are being explored in the fentanyl era 3. Studies show mean day 1 doses of 40.7 mg (pooled weighted mean), increasing to 70.2 mg by day 5 and 81.9 mg by day 7 3. However, this evidence is observational with very low certainty using GRADE criteria 3, and these accelerated protocols are not yet reflected in FDA labeling.
One bridge clinic study reported mean starting doses of 51.6 mg, but this utilized the "72-hour rule" in a specialized setting with close monitoring 4. For standard outpatient initiation, the FDA-approved conservative approach remains the benchmark.
Critical Safety Considerations
Lower initial doses are mandatory for patients who:
- Have not taken opioids for more than 5 days (loss of tolerance) 1
- Are expected to have low tolerance at treatment entry 1
- Show any signs of sedation or intoxication 1
Common pitfall: Do not determine initial doses based on previous treatment episodes or reported dollars spent on illicit drugs 1. The physiologic reality of current tolerance—not historical use—dictates safe starting doses.
The gap between evidence-based maintenance dosing (≥80 mg/day) and actual practice remains problematic, with approximately 42% of patients receiving subtherapeutic doses 5. However, reaching these therapeutic doses requires careful, supervised titration from the conservative starting point of 20-30 mg to prevent early treatment deaths.